NNVC Ships Monkeypox Treatment
NanoViricides ships NV-387 oral gummies to the Democratic Republic of Congo for its Phase II clinical trial of monkeypox treatment
NanoViricides Ships NV-387 Oral Gummies To The Democratic Republic of Congo Ahead Of Patient Enrollment For Its Phase II Clinical Trial Of Monkeypox Treatment